|  |  | 

India Top Headlines

Government and Pfizer work together for the earliest possible import of the vaccine: VK Paul | India News


NEW DELHI: As soon as Pfizer indicated the availability of the vaccine, the central government and the company began working together for the earliest possible import of the vaccine, VK Paul, a member of NITI Aayog, said Thursday.
Paul, in a statement on ‘Myths and Facts About India’s Vaccination Process’, noted that vaccines are in limited supply globally, and companies have their own priorities, game plans and compulsions in allocating stocks. finite.
“As soon as Pfizer indicated the availability of the vaccine, the central government and the company are working together for the earliest possible import of the vaccine,” said Paul, who is also the head of India’s Covid-19 working group. .
Paul, chairman of the National Group of Experts on Vaccine Administration for Covid-19 (NEGVAC), has said that as a result of central government efforts, trials of the Sputnik vaccine were accelerated and, with timely approval, Russia has already shipped two tranches of vaccines. and technology transfer achieved to Indian companies that would start manufacturing very soon.
“We reiterate our request to all international vaccine manufacturers to come and manufacture in India, for India and for the world,” he said.
NITI member Aayog said the Center has continuously engaged with major international vaccine manufacturers since mid-2020. “Multiple rounds of discussions have been held with Pfizer, J&J & Moderna. The government offered all assistance for them to supply and / or manufacture their vaccines in India, “he said.
However, Paul pointed out, it’s not that his vaccines are available in a free supply. “We need to understand that buying vaccines internationally is not similar to buying ‘ready-to-use’ items,” he said.
According to sources, Pfizer has told Indian authorities that its jab has shown “high efficacy” against the variant of SARS-CoV-2 that is prevalent in India and in people of Indian ethnicity or nationality, while it is suitable for all People 12 years and older can be stored for a month at 2-8 degrees.
Pfizer, which is set to offer 5 million rupees doses to India between July and October this year, has sought certain relaxations, including compensation, has had a number of interactions with Indian government authorities recently, including one this week. , during which he shared the most recent data points on efficacy trials and approvals of his vaccine in various countries and by the World Health Organization (WHO).
Paul also refuted claims by some opposition leaders that the Center is not doing enough to increase domestic vaccine production.
“The central government is playing the role of an effective facilitator to enable more companies to produce vaccines starting in early 2020.
“There is only one Indian company (Bharat Biotech) that has the intellectual property. The Government of India has ensured that 3 other companies / plants will start Covaxin production in addition to upgrading Bharat Biotech’s own plants, which have increased from 1 to 4 “. argument.
Paul further said that Covaxin production by Bharat Biotech will increase from less than 1 crore per month to 10 crore per month in October.
Currently India primarily uses two ‘made in India’ jabs (Covishield made by the Serum Institute and Covaxin from Bharat Biotech) and smaller scale Russian made Sputnik V to inoculate its population, all of which are approved for humans only. of advanced age. 18 years and over.
In its latest communication to the government, Pfizer also thanked the government of India for accepting its acquisition request through a central government channel and discussing “indemnity and liability protection”.

Times of India